Fidelity Investments
CMTA

Fidelity Investments’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Fidelity Investments’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-500,000
Closed -$6.58M – 3906
2018
Q2 		$6.58M Hold
500,000
– – ﹤0.01% 2072
2018
Q1 		$7.58M Hold
500,000
– – ﹤0.01% 2032
2017
Q4 		$9.49M Hold
500,000
– – ﹤0.01% 1970
2017
Q3 		$8.45M Buy
+500,000
New +$8.17M ﹤0.01% 2001

Other funds holding CMTA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Fidelity Investments's CMTA Position: Q3 2018 in Review

Fidelity Investments sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q3 2018, closing a stake of 500,000 shares — an estimated $6.58M sold.

Fidelity Investments first reported a position in CMTA in Q3 2017 and held it in 4 quarters. The position peaked at $9.49M in Q4 2017. 27 funds tracked by Wall St. Rank hold CMTA as of Q3 2018.

  • Fidelity Investments reported no remaining Clementia Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Fidelity Investments sold 500,000 Clementia Pharmaceuticals Inc. shares in Q3 2018, an estimated $6.58M.
  • Fidelity Investments first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 4 quarters.
  • Fidelity Investments's Clementia Pharmaceuticals Inc. position peaked at $9.49M in Q4 2017.
  • 27 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q3 2018.

Based on Fidelity Investments's 13F filing for Q3 2018, filed 9 Nov 2018.